Glen Harbor Capital Management’s AstraZeneca AZN Stock Holding History

Glen Harbor Capital Management’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	$597K	Buy	6,692 +2,674	+67%	+$232K	0.01%	644
2019 Q2	$332K	Buy	4,018 +630	+19%	+$49.4K	0.01%	849
2019 Q1	$274K	Buy	3,388 +714	+27%	+$56.3K	0.01%	894
2018 Q4	$203K	Sell	2,674 -5,292	-66%	-$413K	﹤0.01%	940
2018 Q3	$630K	Hold	7,966	–	–	0.01%	622
2018 Q2	$559K	Buy	7,966 +448	+6%	+$32.2K	0.01%	606
2018 Q1	$526K	Hold	7,518	–	–	0.01%	619
2017 Q4	$522K	Hold	7,518	–	–	0.01%	629
2017 Q3	$509K	Hold	7,518	–	–	0.01%	592
2017 Q2	$512K	Hold	7,518	–	–	0.01%	590
2017 Q1	$468K	Hold	7,518	–	–	0.01%	573
2016 Q4	$411K	Buy	+7,518	New	+$427K	0.01%	549

Other funds holding AZN

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Glen Harbor Capital Management's AZN Position: Q3 2019 in Review

Glen Harbor Capital Management increased its AstraZeneca (AZN) stake by 67% in Q3 2019, buying an estimated $232K and bringing the position to 6,692 shares worth $597K. The position accounts for 0.01% of the portfolio, ranked #644.

Glen Harbor Capital Management first reported a position in AZN in Q4 2016 and has held it in 12 quarters since. The position peaked at $630K in Q3 2018. 555 funds tracked by Wall St. Rank hold AZN as of Q3 2019.

Glen Harbor Capital Management held 6,692 shares of AstraZeneca worth $597K as of Q3 2019.
Glen Harbor Capital Management bought 2,674 AstraZeneca shares in Q3 2019, an estimated $232K.
AstraZeneca made up 0.01% of Glen Harbor Capital Management's portfolio in Q3 2019, its #644 holding.
Glen Harbor Capital Management first reported a position in AstraZeneca in Q4 2016 and has held it in 12 quarters since.
Glen Harbor Capital Management's AstraZeneca position peaked at $630K in Q3 2018.
555 funds tracked by Wall St. Rank held AstraZeneca as of Q3 2019.

Based on Glen Harbor Capital Management's 13F filing for Q3 2019, filed 13 Nov 2019.